BOSTON, Feb. 23, 2011 /PRNewswire/ — Solos Endoscopy, Inc.
(Pink Sheets:
SNDY) is pleased to announce that the Company is set to
introduce a new product line consisting of urology surgical and
diagnostic instruments. The line will feature approximately 10
instruments, six of which are modifications to current product
offerings, and five completely redesigned instruments; all of which
have FDA clearance.
Solos’ focus is to strengthen its domestic market share in the
industry through the implementation of several strategies and the
addition of new product lines throughout 2011. In addition, Solos
will continue building product awareness and is currently in the
process of updating its corporate website. Finally, the Company
plans to expand its research and development efforts to develop new
instrumentation to better assist physicians.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose
mission is to develop and market high quality and innovative
instruments for the screening, diagnosis, treatment and management
of medical conditions. Additional information on its FDA approved
products is available on the Company’s website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 27E of the Securities Act of 1934. Statements contained in
this release that are not historical facts may be deemed to be
forward-looking statements. Investors are cautioned that
forward-looking statements are inherently uncertain. Actual
performance and results may differ materially from that projected
or suggested herein due to certain risks and uncertainties
including, without limitation, ability to obtain financing and
regulatory and shareholder approval for anticipate
‘/>”/>
SOURCE
